1-13 of 13
Scott F. Huntington
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Brentuximab vedotin plus AVD for Hodgkin lymphoma: incidence and management of peripheral neuropathy in a multisite cohort

Jackson T. Bowers, Jacob Anna, Steven M. Bair, Kaitlin Annunzio, Narendranath Epperla, Jerrin Joy Pullukkara, Sameh Gaballa, Michael A. Spinner, Shuning Li, Marcus R. Messmer, Joseph Nguyen, Emily C. Ayers, Charlotte B. Wagner, Boyu Hu, Mengyang Di, Scott F. Huntington, Fateeha Furqan, Nirav N. Shah, Christina Chen, Hatcher J. Ballard, Mitchell E. Hughes, Elise A. Chong, Sunita D. Nasta, Stefan K. Barta, Daniel J. Landsburg, Jakub Svoboda
Journal: Blood Advances
Blood Adv (2023) 7 (21): 6630–6638.
https://doi.org/10.1182/bloodadvances.2023010622
Published: 2023
Includes: Supplemental data
Journal Articles

Older patients with chronic myeloid leukemia face suboptimal molecular testing and tyrosine kinase inhibitor adherence

Rory M. Shallis, Rong Wang, Amer M. Zeidan, Scott F. Huntington, Natalia Neparidze, Jessica M. Stempel, Lourdes M. Mendez, Mengyang Di, Xiaomei Ma, Nikolai A. Podoltsev
Journal: Blood Advances
Blood Adv (2023) 7 (13): 3213–3224.
https://doi.org/10.1182/bloodadvances.2022009074
Published: 2023
Journal Articles

Balancing considerations and qualifying conclusions for cost-effectiveness of therapies for relapsed/refractory follicular lymphoma

Kunal C. Potnis, Scott F. Huntington
Journal: Blood Advances
Blood Adv (2023) 7 (11): 2573–2574.
https://doi.org/10.1182/bloodadvances.2023009864
Published: 2023
Journal Articles

Cost-effectiveness of chimeric antigen receptor T-cell therapy in adults with relapsed or refractory follicular lymphoma

Kunal C. Potnis, Mengyang Di, Iris Isufi, Lohith Gowda, Stuart E. Seropian, Francine M. Foss, Howard P. Forman, Scott F. Huntington
Journal: Blood Advances
Blood Adv (2023) 7 (5): 801–810.
https://doi.org/10.1182/bloodadvances.2022008097
Published: 2023
Includes: Supplemental data
Journal Articles

Second malignancies among older patients with classical myeloproliferative neoplasms treated with hydroxyurea

Rong Wang, Rory M. Shallis, Jessica M. Stempel, Scott F. Huntington, Amer M. Zeidan, Steven D. Gore, Xiaomei Ma, Nikolai A. Podoltsev
Journal: Blood Advances
Blood Adv (2023) 7 (5): 734–743.
https://doi.org/10.1182/bloodadvances.2022008259
Published: 2023
Journal Articles

Survival of mantle cell lymphoma in the era of Bruton tyrosine kinase inhibitors: a population-based analysis

Mengyang Di, Can Cui, Shalin K. Kothari, Amer M. Zeidan, Nikolai A. Podoltsev, Natalia Neparidze, Rory M. Shallis, Rong Wang, Xiaomei Ma, Scott F. Huntington
Journal: Blood Advances
Blood Adv (2022) 6 (11): 3339–3342.
https://doi.org/10.1182/bloodadvances.2021006934
Published: 2022
Includes: Supplemental data
Journal Articles

Practice patterns and real-life outcomes for patients with acute promyelocytic leukemia in the United States

Clinical Trials & Observations
Jan Philipp Bewersdorf, Stephanie Prozora, Nikolai A. Podoltsev, Rory M. Shallis, Scott F. Huntington, Natalia Neparidze, Rong Wang, Amer M. Zeidan, Amy J. Davidoff
Journal: Blood Advances
Blood Adv (2022) 6 (2): 376–385.
https://doi.org/10.1182/bloodadvances.2021005642
Published: 2022
Includes: Supplemental data
Journal Articles

Cost-effectiveness analysis of oral azacitidine maintenance therapy in acute myeloid leukemia

Clinical Trials & Observations
Jan Philipp Bewersdorf, Kishan K. Patel, Scott F. Huntington, Amer M. Zeidan
Journal: Blood Advances
Blood Adv (2021) 5 (22): 4686–4690.
https://doi.org/10.1182/bloodadvances.2021005472
Published: 2021
Includes: Supplemental data
Journal Articles

Cost-effectiveness of azacitidine and venetoclax in unfit patients with previously untreated acute myeloid leukemia

Kishan K. Patel, Amer M. Zeidan, Rory M. Shallis, Thomas Prebet, Nikolai Podoltsev, Scott F. Huntington
Journal: Blood Advances
Blood Adv (2021) 5 (4): 994–1002.
https://doi.org/10.1182/bloodadvances.2020003902
Published: 2021
Includes: Supplemental data
Journal Articles

Chromosome 1 abnormalities and survival of patients with multiple myeloma in the era of novel agents

Clinical Trials & Observations
Smith Giri, Scott F. Huntington, Rong Wang, Amer M. Zeidan, Nikolai Podoltsev, Steven D. Gore, Xiaomei Ma, Cary P. Gross, Amy J. Davidoff, Natalia Neparidze
Journal: Blood Advances
Blood Adv (2020) 4 (10): 2245–2253.
https://doi.org/10.1182/bloodadvances.2019001425
Published: 2020
Journal Articles

Clinical outcomes of older patients with AML receiving hypomethylating agents: a large population-based study in the United States

Clinical Trials & Observations
Amer M. Zeidan, Rong Wang, Xiaoyi Wang, Rory M. Shallis, Nikolai A. Podoltsev, Jan P. Bewersdorf, Scott F. Huntington, Natalia Neparidze, Smith Giri, Steven D. Gore, Amy J. Davidoff, Xiaomei Ma
Journal: Blood Advances
Blood Adv (2020) 4 (10): 2192–2201.
https://doi.org/10.1182/bloodadvances.2020001779
Published: 2020
Includes: Supplemental data
Journal Articles

Patterns of care and clinical outcomes with cytarabine-anthracycline induction chemotherapy for AML patients in the United States

Amer M. Zeidan, Nikolai A. Podoltsev, Xiaoyi Wang, Chi Zhang, Jan Philipp Bewersdorf, Rory M. Shallis, Scott F. Huntington, Natalia Neparidze, Smith Giri, Steven D. Gore, Amy J. Davidoff, Xiaomei Ma, Rong Wang
Journal: Blood Advances
Blood Adv (2020) 4 (8): 1615–1623.
https://doi.org/10.1182/bloodadvances.2020001728
Published: 2020
Journal Articles

The impact of phlebotomy and hydroxyurea on survival and risk of thrombosis among older patients with polycythemia vera

Clinical Trials & Observations
Nikolai A. Podoltsev, Mengxin Zhu, Amer M. Zeidan, Rong Wang, Xiaoyi Wang, Amy J. Davidoff, Scott F. Huntington, Smith Giri, Steven D. Gore, Xiaomei Ma
Journal: Blood Advances
Blood Adv (2018) 2 (20): 2681–2690.
https://doi.org/10.1182/bloodadvances.2018021436
Published: 2018
Includes: Supplemental data